Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Hobart

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Multiple Sclerosis and Related Disorders|September 20, 2016
Brain health: time matters in multiple sclerosisGavin Giovannoni, Helmut Butzkueven, Suhayl Dhib-Jalbut, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 28, 2015
Clinical Outcome Assessments: Conceptual Foundation-Report of the ISPOR Clinical Outcomes Assessment - Emerging Good Practices for Outcomes Research Task ForceMarc K Walton, John H Powers, Jeremy Hobart, et al.
BMC Neurology|March 28, 2024
Delays in Multiple Sclerosis diagnosis (DIMES): protocol for a multicentre, observational study of multiple sclerosis diagnostic pathways in the United Kingdom and Republic of IrelandAshvin Kuri, David E Henshall, Daoud Chaudhry, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 27, 2022
Patient-reported outcome measures in MS: Do development processes and patient involvement support valid quantification of clinically important variables?Trishna Bharadia, Jo Vandercappellen, Tanuja Chitnis, et al.
Health Technology Assessment (Winchester, England)|February 14, 2015
The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosisSusan Ball, Jane Vickery, Jeremy Hobart, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 19, 2017
Clinician-Reported Outcome Assessments of Treatment Benefit: Report of the ISPOR Clinical Outcome Assessment Emerging Good Practices Task ForceJohn H Powers, Donald L Patrick, Marc K Walton, et al.
Multiple Sclerosis and Related Disorders|December 6, 2021
Factors contributing to CSF NfL reduction over time in those starting treatment for multiple sclerosis: An observational studyIde Smets, David Holden, Lucia Bianchi, et al.
CNS Drugs|December 12, 2018
Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III ENHANCE Trial of Prolonged-Release FampridineJeremy Hobart, Tjalf Ziemssen, Peter Feys, et al.
Therapeutic Advances in Neurological Disorders|October 12, 2018
Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience. Report of an expert meetingPhilipp Albrecht, Ingrid Kristine Bjørnå, David Brassat, et al.
Practical Neurology|November 12, 2024
Using disease-modifying treatments in multiple sclerosis: Association of British Neurologists (ABN) 2024 guidanceWaqar Rashid, Olga Ciccarelli, Siobhan M Leary, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Multiple Sclerosis and Related Disorders|September 20, 2016
Brain health: time matters in multiple sclerosisGavin Giovannoni, Helmut Butzkueven, Suhayl Dhib-Jalbut, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 28, 2015
Clinical Outcome Assessments: Conceptual Foundation-Report of the ISPOR Clinical Outcomes Assessment - Emerging Good Practices for Outcomes Research Task ForceMarc K Walton, John H Powers, Jeremy Hobart, et al.
BMC Neurology|March 28, 2024
Delays in Multiple Sclerosis diagnosis (DIMES): protocol for a multicentre, observational study of multiple sclerosis diagnostic pathways in the United Kingdom and Republic of IrelandAshvin Kuri, David E Henshall, Daoud Chaudhry, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 27, 2022
Patient-reported outcome measures in MS: Do development processes and patient involvement support valid quantification of clinically important variables?Trishna Bharadia, Jo Vandercappellen, Tanuja Chitnis, et al.
Health Technology Assessment (Winchester, England)|February 14, 2015
The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosisSusan Ball, Jane Vickery, Jeremy Hobart, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 19, 2017
Clinician-Reported Outcome Assessments of Treatment Benefit: Report of the ISPOR Clinical Outcome Assessment Emerging Good Practices Task ForceJohn H Powers, Donald L Patrick, Marc K Walton, et al.
Multiple Sclerosis and Related Disorders|December 6, 2021
Factors contributing to CSF NfL reduction over time in those starting treatment for multiple sclerosis: An observational studyIde Smets, David Holden, Lucia Bianchi, et al.
CNS Drugs|December 12, 2018
Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III ENHANCE Trial of Prolonged-Release FampridineJeremy Hobart, Tjalf Ziemssen, Peter Feys, et al.
Therapeutic Advances in Neurological Disorders|October 12, 2018
Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience. Report of an expert meetingPhilipp Albrecht, Ingrid Kristine Bjørnå, David Brassat, et al.
Practical Neurology|November 12, 2024
Using disease-modifying treatments in multiple sclerosis: Association of British Neurologists (ABN) 2024 guidanceWaqar Rashid, Olga Ciccarelli, Siobhan M Leary, et al.
Pageof 7